BioSpace News Archive

Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune disorders, announced the appointment of Hugo Fry as its new Chief Executive Officer.

MediciNova, Inc. announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166.

Insulet Corporation released its 2023 Sustainability Report, which describes key accomplishments in environmental, social, and governance areas in 2023.

Biodesix, Inc. announced that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the 2024 RBCCM Global Healthcare Conference, which will be held from May 14-15, 2024.

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, reported financial results for the first quarter ended March 30, 2024.

Broken String Biosciences announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease.

IGM Biosciences, Inc. announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT.

Zentalis® Pharmaceuticals, Inc. announced financial results for the quarter ended March 31, 2024, and highlighted recent corporate accomplishments.

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.

Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, announced four oral and four poster presentations from across its hematopoietic stem cell gene therapy platform will be featured at the 27th Annual Meeting of the American Society of Gene and Cell Therapy taking place May 7-11, 2024, in Baltimore.